BG103207A - Естери на арилциклоалканкарбоксилни киселини, тяхното използване, фармацевтични състави и получаването им - Google Patents

Естери на арилциклоалканкарбоксилни киселини, тяхното използване, фармацевтични състави и получаването им

Info

Publication number
BG103207A
BG103207A BG103207A BG10320799A BG103207A BG 103207 A BG103207 A BG 103207A BG 103207 A BG103207 A BG 103207A BG 10320799 A BG10320799 A BG 10320799A BG 103207 A BG103207 A BG 103207A
Authority
BG
Bulgaria
Prior art keywords
ring
atom
pharmaceutical compositions
optionally substituted
lower alkyl
Prior art date
Application number
BG103207A
Other languages
English (en)
Inventor
Eva Akerblom
Martin Haraldsson
Rolf Johansson
Katarina Beierlein
Birger Sjoberg
Erik Ringberg
Birgitta Weinz
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9602890A external-priority patent/SE9602890D0/xx
Priority claimed from SE9602889A external-priority patent/SE9602889D0/xx
Priority claimed from SE9602888A external-priority patent/SE9602888D0/xx
Priority claimed from SE9602887A external-priority patent/SE9602887D0/xx
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of BG103207A publication Critical patent/BG103207A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/12—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Съединенията се използват за лечение на незадържане на урина или синдром на дразнене на тънките черва. Те имат формула, в която А е в даден случай заместен циклоалканов пръстен с 3 до 6 въглеродни атома и е свързан с единия въглероден атом от пръстена; Ar е фенил или хетероарил с 5 до 6 атомен пръстен; R1 и R2, независимо един от друг, означават водород, нисш алкил, нисш алкокси, халоген, хидрокси, трифлуорометил, нитро или амино, или R1 и R2 заедно образуват нисш алкилендиокси или в даден случай заместен бензо; и R3 e -(CH2)nNR10R11, където nима стойност 2 или 3 и R10 и R11 поотделно означават нисш алкил или R10 и R11 заедно с азотния атомобразуват наситена азициклична или азабициклична пръстенна система; или R3 означава -(CH2)m-Q, в която m е 0 или 1 и Q е остатък от наситена азациклична или азабициклична пръстенна система, свързан чрез неин въглероден атом. Изобретението се отнася също и до фармакологично приемливи соли на посочените съединения, до тяхното получаване и до нови фармацевтични състави.
BG103207A 1996-07-29 1999-02-25 Естери на арилциклоалканкарбоксилни киселини, тяхното използване, фармацевтични състави и получаването им BG103207A (bg)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9602890A SE9602890D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602889A SE9602889D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602888A SE9602888D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
SE9602887A SE9602887D0 (sv) 1996-07-29 1996-07-29 Carboxylic esters, their use and preparation
PCT/SE1997/001310 WO1998004517A1 (en) 1996-07-29 1997-07-23 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation

Publications (1)

Publication Number Publication Date
BG103207A true BG103207A (bg) 1999-10-29

Family

ID=27484794

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103207A BG103207A (bg) 1996-07-29 1999-02-25 Естери на арилциклоалканкарбоксилни киселини, тяхното използване, фармацевтични състави и получаването им

Country Status (17)

Country Link
US (1) US6124354A (bg)
EP (1) EP0923536A1 (bg)
JP (1) JP2000515881A (bg)
KR (1) KR20000029703A (bg)
CN (1) CN1226886A (bg)
AU (1) AU724563B2 (bg)
BG (1) BG103207A (bg)
BR (1) BR9710614A (bg)
CA (1) CA2261692A1 (bg)
EE (1) EE9900034A (bg)
IL (1) IL128096A0 (bg)
NO (1) NO990335L (bg)
NZ (1) NZ333798A (bg)
PL (1) PL331384A1 (bg)
SK (1) SK4699A3 (bg)
TR (1) TR199900185T2 (bg)
WO (1) WO1998004517A1 (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020547A1 (es) 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma
MXPA04003806A (es) * 2001-11-05 2005-04-08 Upjohn Co Aerosol antimuscarinico.
CA2513188A1 (en) * 2003-01-16 2004-08-05 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
WO2008059239A1 (en) * 2006-11-14 2008-05-22 Astrazeneca Ab Novel compounds 514
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
US20110190309A1 (en) * 2008-05-13 2011-08-04 Rhonan Ford PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST
EP2300464A1 (en) 2008-05-13 2011-03-30 AstraZeneca AB Quinuclidine derivatives as muscarinic m3 receptor antagonists
EP2699539B1 (en) * 2011-04-21 2019-03-06 Emory University Cyclopropyl derivatives and methods of use
JOP20130273B1 (ar) 2012-09-11 2021-08-17 Genzyme Corp مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
TW201617343A (zh) * 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
CN106083615B (zh) * 2016-06-08 2019-03-08 山东省药学科学院 一种盐酸环喷托酯的制备方法
US11274100B2 (en) 2017-06-21 2022-03-15 Daiichi Sankyo Company, Limited EP300/CREBBP inhibitor
BR112022014553A2 (pt) 2020-02-03 2022-09-20 Genzyme Corp Métodos para tratamento de sintomas neurológicos associados a doenças do armazenamento lisossômic
CA3186766A1 (en) 2020-07-24 2022-01-27 Danielle Combessis Pharmaceutical compositions comprising venglustat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168881A1 (en) * 1972-01-25 1973-09-07 Synthelabo Tropanol 1-phenylcycloalkane carboxylic ester salts - spasmolytics and cholinergics
US4418202A (en) * 1981-12-21 1983-11-29 Emery Industries, Inc. 2-Vinyl- and 2-ethylcyclopropane monocarboxylates
DD289411A7 (de) * 1984-06-29 1991-05-02 Arzneimittelwerk Dresden Gmbh,De Verfahren zur herstellung eines antidos fuer phosphororganische verbindungen
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
US5086054A (en) * 1990-07-31 1992-02-04 Sri International Novel arylcycloalkanepolyalkylamines
US5064850A (en) * 1991-04-08 1991-11-12 Marion Merrell Dow Inc. Dihydro-3,3-diphenyl-5-(1H-pyrazol-1-ylmethyl-2(3H)-furanone and dihydro-5-((substituted-1H-pyrazol-1-yl)methyl)-3,3-diphenyl-2(3H)-furanone derivatives
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands

Also Published As

Publication number Publication date
IL128096A0 (en) 1999-11-30
US6124354A (en) 2000-09-26
PL331384A1 (en) 1999-07-05
NO990335L (no) 1999-03-29
AU724563B2 (en) 2000-09-28
WO1998004517A1 (en) 1998-02-05
KR20000029703A (ko) 2000-05-25
BR9710614A (pt) 2000-01-11
AU3790597A (en) 1998-02-20
JP2000515881A (ja) 2000-11-28
NO990335D0 (no) 1999-01-25
CN1226886A (zh) 1999-08-25
EE9900034A (et) 1999-08-16
NZ333798A (en) 2000-08-25
SK4699A3 (en) 2000-04-10
EP0923536A1 (en) 1999-06-23
TR199900185T2 (xx) 1999-04-21
CA2261692A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
BG103207A (bg) Естери на арилциклоалканкарбоксилни киселини, тяхното използване, фармацевтични състави и получаването им
DE3272792D1 (en) Process for the preparation of 2-penem compounds
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
ES8106723A1 (es) Un metodo para la preparacion de derivados de ftalimidina
HUP9802937A2 (hu) Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
TW375615B (en) Galanthamine derivatives and their use as medicaments
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
ES8502099A1 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
HUT35254A (en) Process for preparing new cyclobutyl-alkyl-amine compounds with pharmaceutical activity and salts thereof
HUT37431A (en) Process for the production of imidazo /1,2-c/pyrimidines and of their salts,as well as of therapeutic preparations containing these compounds as agent
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0105426A2 (hu) 3-(2-oxo-[1,3&#39;]bipirrolidinil-3-ilidén-metil)-cefém-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP9702038A2 (hu) Fenil-szubsztituált 4-aza-szteroidok fluorszármazékai, eljárás előállításukra, alkalmazásuk, ezeket tartalmazó gyógyszerkészítmények
HUP0201863A2 (hu) Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
EA199800085A1 (ru) Способ лечения боли висцерального происхождения, способ лечения воспалительного колита
ZA200200009B (en) Novel fluorinated benzodioxane imidazoline derivatives, their preparation and their therapeutic applications.
ES8707951A1 (es) Derivados de tetrazol
SE8302452D0 (sv) Method for treatment of senile dementia
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
WO2000008006A3 (en) Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them